TSO for Plaque Psoriasis
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Plaque Psoriasis
Related studies linked through entity extraction aliases.
Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients
- Status
- COMPLETED
- Phase
- PHASE3
Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%
- Status
- COMPLETED
- Phase
- PHASE4
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)
- Status
- COMPLETED
- Phase
- PHASE3
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
- Status
- COMPLETED
- Phase
- PHASE4
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis
- Status
- WITHDRAWN
- Phase
- PHASE3
Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011)
- Status
- COMPLETED
- Phase
- PHASE3
LAS41008 in Moderate to Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
- Status
- COMPLETED
- Phase
- PHASE3
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
- Status
- TERMINATED
- Phase
- PHASE3
Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation
- Status
- COMPLETED
- Phase
- N/A
Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris
- Status
- COMPLETED
- Phase
- PHASE4